60
Views
12
CrossRef citations to date
0
Altmetric
Review

Atrial fibrillation and thromboprophylaxis in heart failure: the need for patient-centered approaches to address adherence

, , , , &
Pages 3-11 | Published online: 17 Jan 2013

References

  • KrumHJelinekMVStewartSSindoneAAthertonJJ2011Update to National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand Guidelines for the prevention, detection and management of chronic heart failure in Australia, 2006Med J Aust2011194840540921495941
  • GheorghiadeMFilippatosGReassessing treatment of acute heart failure syndromes: the ADHERE RegistryEur Heart J Suppl.20057Suppl BB1319
  • PullicinoPHommaSStroke in heart failure: atrial fibrillation revisited?J Stroke Cerebrovasc Dis20101911220123219
  • Atrial fibrillation [webpage on the Internet]Atrial fibrillation (CG36): the management of atrial fibrillationNational Institute for Health and Clinical Excellence2006 [updated July 10, 2012]. Available from: http://www.nice.org.uk/cg36Accessed December 17, 2012
  • WannLSCurtisABJanuaryCT2011ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuidelinesCirculation2011123110412321173346
  • FusterVRydenLECannomDSACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice GuidelinesCirculation20061147e257e35416908781
  • OgilvieIMNewtonNWelnerSACowellWLipGYUnderuse of oral anticoagulants in atrial fibrillation: a systematic reviewAm J Med2010123763864520609686
  • SingerDEAlbersGWDalenJEAntithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, 8th edChest2008133Suppl 6546S592S18574273
  • GattellariMWorthingtonJZwarNMiddletonSBarriers to the use of anticoagulation for nonvalvular atrial fibrillation: a representative survey of Australian family physiciansStroke200839122723018048861
  • BaczekVTLChenWTKlugerJColemanCIPredictors of warfarin use in atrial fibrillation in the United States: a systematic review and meta-analysisBMC Fam Pract2012131522304704
  • HaynesRBAcklooESahotaNMcDonaldHPYaoXInterventions for enhancing medication adherenceCochrane Database Syst Rev20082CD00001118425859
  • PereraVBajorekBVMatthewsSHilmerSNThe impact of fraility on the utilisation of antithrombotic therapy in older patients with atrial fibrillationAge Ageing200938215616219151165
  • LipGYImplications of the CHA2DS2-VASc and HAS-BLED scores for thromboprophylaxis in atrial fibrillationAm J Med2011124211111420887966
  • MantJHobbsFDFletcherKWarfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trialLancet2007370958649350317693178
  • HommaSThompsonJLPPullicinoPMWarfarin and aspirin in patients with heart failure and sinus rhythmNew Engl J Med Epub May 2, 2012
  • WangTJMassaroJMLevyDA risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart StudyJAMA200329081049105612941677
  • LipGYHalperinJLImproving stroke risk stratification in atrial fibrillationAm J Med2010123648448820569748
  • GageBFWatermanADShannonWBoechlerMRichMWRadfordMJValidation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial FibrillationJAMA2001285222864287011401607
  • HartRGPearceLAMcBrideRRothbartRMAsingerRWFactors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I–III clinical trialsStroke19993061223122910356104
  • BaruchLGageBFHorrowJCan patients at elevated risk of stroke treated with anticoagulants be further risk stratified?Stroke20073892459246317673721
  • BorianiGBottoGLPadelettiLImproving stroke risk stratification using the CHADS2 and CHA2DS2VASc risk scores in patients with paroxysmal atrial fibrillation by continuous arrhythmia burden monitoringStroke20114261768177021493904
  • GageBFYanYMilliganPEClinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF)Am Heart J2006151371371916504638
  • LipGYFrisonLHalperinJLLaneDAComparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) scoreJ Am Coll Cardiol201157217318021111555
  • ShiremanTIHowardPAKresowikTFEllerbeckEFCombined anticoagulant–antiplatelet use and major bleeding events in elderly atrial fibrillation patientsStroke200435102362236715331796
  • BeythRJQuinnLMLandefeldCSProspective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarinAm J Med1998105291999727814
  • KuijerPMHuttenBAPrinsMHBullerHRPrediction of the risk of bleeding during anticoagulant treatment for venous thromboembolismArch Intern Med1999159545746010074953
  • KomajdaMLapuertaPHermansNAdherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER surveyEur Heart J200526161653165915827061
  • World Health OrganizationAdherence to Long Term Therapies: Evidence for ActionGenevaWorld Health Organization2003 Available from: http://whqlibdoc.who.int/publications/2003/9241545992.pdfAccessed December 17, 2012
  • PicciniJPHernandezAFZhaoXQuality of care for atrial fibrillation among patients hospitalized for heart failureJ Am Coll Cardiol200954141280128919778670
  • NieuwlaatREurlingsLWClelandJGAtrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillationJ Am Coll Cardiol200953181690169819406345
  • LipGYStroke in atrial fibrillation: epidemiology and thromboprophylaxisJ Thromb Haemost20119Suppl 1S344351
  • GoASEfficacy of anticoagulation for stroke prevention and risk stratification in atrial fibrillation: translating trials into clinical practiceAm J Manag Care200410Suppl 3S586515152747
  • EzekowitzMBridgersSLJamesKEVeterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation InvestigatorsWarfarin in the prevention of stroke associated with nonrheumatic atrial fibrillationNew Engl J Med199232720140614121406859
  • Atrial Fibrillation InvestigatorsRisk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trialsArch Intern Med199415413144914578018000
  • Stroke Prevention In Atrial Fibrillation InvestigatorsStroke prevention in atrial fibrillation trial. Final resultsCirculation19918425275391860198
  • MillerCSGrandiSMShimonyAFilionKBEisenbergMJMeta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillationAm J Cardiol2012110345346022537354
  • AgarwalSHachamovitchRMenonVCurrent trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysisArch Intern Med2012172862363122450212
  • MarinighRLipGYFiottiNGiansanteCLaneDAAge as a risk factor for stroke in atrial fibrillation patients: implications for thrombophrophylaxisJ Am Coll Cardiol2010561182783720813280
  • FangMCGoASChangYWarfarin discontinuation after starting warfarin for atrial fibrillationCirc Cardiovasc Qual Outcomes20103662463120959565
  • FribergLRosenqvistMLipGYNet clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort studyCirculation2012125192298230722514252
  • BajorekBVOgleSJDuguidMJShenfieldGMKrassIManagement of warfarin in atrial fibrillation: views of health professionals, older patienst and their carersMed J Aust2007186417518017309417
  • BoSValpredaSScaglioneLImplementing hospital guidelines improves warfarin use in non-valvular atrial fibrillation: a before–after studyBMC Public Health20077120317692112
  • BrophyMTSnyderKEGaehdeSIvesCGagnonDFioreLDAnticoagulant use for atrial fibrillation in the elderlyJ Am Geriatr Soc20045271151115615209654
  • SrivastavaAHudsonMHamoudICavalcanteJPaiCKaatzSExamining warfarin underutilization rates in patients with atrial fibrillation: detailed chart review essential to capture contraindications to warfarin therapyThromb J20086618522741
  • TulnerLRVan CampenJPKuperIMReasons for undertreatment with oral anticoagulants in frail geriatric outpatients with atrial fibrillationDrugs Aging2010271395020030431
  • GrimshawJMRussellITEffect of clinical guidelines on medical practice: a systematic review of rigorous evaluationsLancet19933428883131713227901634
  • CabanaMDRandCSPoweNRWhy don’t physicians follow clinical practice guidelines? A framework for improvementJAMA1999282151458146510535437
  • RewiukKWiznerBFedyk-LukasikMHeart failure and atrial fibrillation – does practice meet the anticoagulation guidelines?Int J Cardiol2012157227427522475842
  • AnsellJHirshJHylekEJacobsonACrowtherMPalaretiGPharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, 8th edChest20081336 Suppl160S198S18574265
  • ConnollySJLaupacisAGentMRobertsRSCairnsJAJoynerCCanadian Atrial Fibrillation Anticoagulation (CAFA) studyJ Am Coll Cardiol19911823493551856403
  • AlbersGWDienerHCFrisonLXimelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trialJAMA2005293669069815701910
  • Stroke Prevention In Atrial Fibrillation InvestigatorsAdjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trialLancet199634890286336388782752
  • AppelboamRThomasEOWarfarin and intracranial haemmorhageBlood Rev20092311918583002
  • SjoblomLHardemarkHGLindgrenAManagement and prognostic features of intracerebral hemmorhage during anticoagulant therapy: a Swedish multicenter studyStroke200132112567257411692018
  • GrangerCBAlexanderJHMcMurrayJJApixaban versus warfarin in patients with atrial fibrillationNew Engl J Med20113651198199221870978
  • PatelMRMahaffeyKWGargJRivaroxaban versus warfarin in nonvalvular atrial fibrillationNew Engl J Med20113651088389121830957
  • ConnollySJEzekowitzMDYusufSDabigatran versus warfarin in patients with atrial fibrillationNew Engl J Med2009361121139115119717844
  • BattinelliEMReversal of new oral anticoagulantsCirculation2011124141508151021969317
  • MussigbrodtAHindricksGClinical implications from recent trials and new guidelines for stroke prevention in atrial fibrillationEur Cardiol201283174178
  • HorstkotteDPiperCImprovement of oral anticoagulation therapy by INR self-managementJ Heart Valve Dis200413333533815222277
  • GiuffridaATorgersonDShould we pay the patient? Review of financial incentives to enhance patient complianceBMJ199731571107037079314754
  • AliABaileyCAbdelhafizAHStroke prophylaxis with warfarin or dabigatran for patients with non-valvular atrial fibrillation-cost analysisAge Ageing201241568168422378612
  • DunlaySMEvelethJMShahNDMcNallanSMRogerVLMedication adherence among community-dwelling patients with heart failureMayo Clin Proc201186427328121389248
  • DolorRJRuybalidRLUyedaLAn evaluation of patient self-testing competency of prothrombin time for managing anticoagulation: pre-randomization results of VA Cooperative Study #481 – The Home INR Study (THINRS)J Thromb Thrombolysis201030326327520628787
  • WuJRMoserDKChungMLLennieTAPredictors of medication adherence using a multidimensional adherence model in patients with heart failureJ Card Fail200814760361418722327
  • BrownSBShannonRPImproving medication compliance in patients with heart failureAm J Cardiol2008101227427718178422
  • van der WalMHJaarsmaTAdherence in heart failure in the elderly: problem and possible solutionsInt J Cardiol2008125220320818031843
  • De SmedtRHDenigPvan der MeerKHaaijer-RuskampFMJaarsmaTSelf-reported adverse drug events and the role of illness perception and medication beliefs in ambulatory heart failure patients: a cross-sectional surveyInt J Nurs Stud201148121540155021774932
  • NEHIThinking outside the pillbox: a system-wide approach to improving patient medication adherence for chronic diseaseCambridge, MANEHI2009 Available from: http://www.nehi.net/publications/44/thinking_outside_the_pillbox_a_systemwide_approach_to_improving_patient_medication_adherence_for_chronic_diseaseAccessed December 6, 2012
  • McCabePJSchumacherKBarnasonSALiving with atrial fibrillation: a qualitative studyJ Cardiovasc Nurs201126433634421263348
  • BajorekBVKrassIOgleSJDuguidMJShenfieldGMOptimizing the use of antithrombotic therapy for atrial fibrillation in older people: a pharmacist-led multidisciplinary interventionJ Am Geriatr Soc200553111912192016274372
  • TangEOLaiCSLeeKKWongRSChengGChanTYRelationship between patients’ warfarin knowledge and anticoagulation controlAnn Pharmacother2003371343912503930
  • InglisSCCarkRAMcAlisterFAStructured telephone support or telemonitoring programmes for patients with chronic heart failureCochrane Database Syst Rev20108CD00722820687083
  • Robert-EbadiHLe GalGRighiniMUse of anticogulants in elderly patients: practical recommendationsClin Interv Aging2009416517719503778
  • SansossianSOvbiageleBPrevention and management of stroke in very elderly patientsLancet Neurol20098111031104119800847
  • KrassIOgleSJDuguidMJShenfieldGMBajorekBVThe impact of age on antithrombotic use in elderly patients with non-valvular atrial fibrillationAustralas J Ageing20022113641
  • GehiAHaasDPipkinSWhooleyMADepression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul StudyArch Intern Med2005165212508251316314548
  • WalkerGAHeidenreichPAPhibbsCSMental illness and warfarin use in atrial fibrillationAm J Manag Care201117961762421902447
  • VaccarinoVKaslSVAbramsonJKrumholzHMDepressive symptoms and risk of functional decline and death in patients with heart failureJ Am Coll Cardiol200138119920511451275
  • FormanDERichMWAlexanderKPCardiac care for older adults. Time for a new paradigmJ Am Coll Cardiol201157181801181021527153
  • FlakerGCPogueJYusufSCognitive function and anticoagulation control in patients with atrial fibrillationCirc Cardiovasc Qual Outcomes20103327728320233976
  • HauptmanPJMedication adherence in heart failureHeart Fail Rev20081319910617479364
  • HylekEMOral anticoagulants. Pharmacologic issues for use in the elderlyClin Geriatr Med200117111311270124
  • MoriskyDEGreenLWLevineDMConcurrent and predictive validity of a self-reported measure of medication adherenceMed Care198624167743945130
  • MarzonaIO’DonnellMTeoKIncreased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studiesCMAJ20121846E32933622371515
  • WongCXBrooksAGLeongDPRoberts-ThomsonKCSandersPThe increasing burden of atrial fibrillation compared with heart failure and myocardial infarction: a 15 year study of all hospitalizations in AustraliaArch Intern Med2012172973974122782205
  • StewartSEpidemiology and economic impact of atrial fibrillationJ Cardiovasc Nurs20041929410215058846
  • McEnteeMLCuomoLRDennisonCRPatient-, provider-, and system-level barriers to heart failure careJ Cardiovasc Nurs200924429029819465864
  • SackettDLRosenbergWMMuir GrayJAHaynesRBRichardsonWSEvidence based medicine: what it is and what it isn’tBMJ1996312702371728555924